Related Experiment Video
Updated: Mar 2, 2026
06:12
Author Spotlight: A Novel Method for Comprehensive Cell Component Analysis of Cerebral Blood Clots
Published on: July 21, 2023
1.1K
Analyses of thrombi in acute ischemic stroke: A consensus statement on current knowledge and future directions
Simon F De Meyer1, Tommy Andersson2,3,4, Blaise Baxter5
11 Laboratory for Thrombosis Research, KU Leuven Campus Kulak Kortrijk, Kortrijk, Belgium.
Summary
Analyzing arterial thrombi from acute ischemic stroke offers new insights into clot composition and characteristics. This research aims to improve stroke treatment and patient outcomes through better understanding and advanced imaging.
Area of Science:
- Neuroscience
- Biomedical Engineering
- Vascular Biology
Background:
- Limited data exists on the composition and characteristics of arterial thrombi in acute ischemic stroke (AIS).
- Advances in endovascular thrombectomy and imaging provide opportunities to study retrieved cerebral artery thrombi.
- Understanding thrombus properties is crucial for improving AIS treatment and secondary prevention strategies.
Purpose of the Study:
- To integrate recent research on clots retrieved from cerebral arteries in AIS.
- To provide a rationale for further analyses of thrombus composition, etiology, and physical properties.
- To highlight opportunities and limitations in current thrombus research for advancing AIS therapy.
Main Methods:
- Review and integration of current scientific literature on cerebral artery thrombi.
- Analysis of opportunities presented by advanced imaging and endovascular thrombectomy.
- Emphasis on interdisciplinary approaches combining clinical, engineering, and scientific perspectives.
Main Results:
- Current imaging provides some thrombus information, but relationships between composition, occlusion, and outcomes require further evaluation.
- Characterizing thrombus types, properties, and temporal changes can enhance revascularization success.
- Interdisciplinary research is essential for advancing the understanding of thrombi in AIS.
Conclusions:
- Further analysis of thrombus composition and characteristics is warranted to improve acute ischemic stroke treatment.
- Advanced imaging and interdisciplinary collaboration are key to unlocking new therapeutic strategies.
- Improved pathophysiological understanding of thrombi will guide more effective secondary prevention and treatment.
Related Concept Videos
01:29Venous Thrombosis III: Interprofessional Care
425
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
425
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
2.1K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.1K
01:20Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
399
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
399
01:30Venous Thrombosis I: Introduction
587
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
587
01:16Clot Retraction and Fibrinolysis
9.7K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
9.7K
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
2.6K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.6K